The rise of iPSC-derived immune cells and CRISPR-based engineering is reshaping functional genomics, but protein-level validation has struggled to keep pace.
PRISM brings together three organizations to standardize and distribute patient-derived iPSC motor neuron models that better represent the biological diversity of ALS.
ISTAND acceptance marks the first stem cell-derived functional cardiac safety assay to enter the program, reflecting FDA interest in human-relevant, non-animal approaches to assessing proarrhythmic risk.
As nearly 90 percent of drugs fail in human trials, researchers are turning to patient-derived cells, engineered tissues, and AI to better predict human responses and reduce costly late-stage failures.
From cell culture media to additive reagents, environmental cues shape cell state and influence the utility of stem cell research models and therapies.
Discover practical strategies to improve pipetting accuracy, reproducibility, ergonomics, and instrument performance across diverse laboratory workflows.